ILC2s release type 2 cytokines (such as IL-5 and IL-13) and growth factors (such as AREG) in inflamed and injured lung tissues in patients with chronic obstructive pulmonary disease and asthma. This evidence concerns the gene IL13 and chronic obstructive pulmonary disease.